The first evidence revealing the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) family of enzymes as endogenous sources of somatic mutations found in human cancer were provided in 2012 by Nik-Zainal et al. [9] and Roberts et al. [10]. Here, APOB is linked to cancer.